[go: up one dir, main page]

SE0303571D0 - Medical product for moisture-sensitive medicaments - Google Patents

Medical product for moisture-sensitive medicaments

Info

Publication number
SE0303571D0
SE0303571D0 SE0303571A SE0303571A SE0303571D0 SE 0303571 D0 SE0303571 D0 SE 0303571D0 SE 0303571 A SE0303571 A SE 0303571A SE 0303571 A SE0303571 A SE 0303571A SE 0303571 D0 SE0303571 D0 SE 0303571D0
Authority
SE
Sweden
Prior art keywords
moisture
medical product
sensitive drugs
drugs
sensitive
Prior art date
Application number
SE0303571A
Other languages
English (en)
Inventor
Thomas Nilsson
Mattias Myrman
Sven Calander
Alf Niemi
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30772322&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0303571(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0303269A external-priority patent/SE0303269L/sv
Application filed by Microdrug Ag filed Critical Microdrug Ag
Priority to SE0303571A priority Critical patent/SE0303571D0/sv
Publication of SE0303571D0 publication Critical patent/SE0303571D0/sv
Priority to US10/921,192 priority patent/US20050123486A1/en
Priority to PCT/SE2004/001793 priority patent/WO2005053647A1/en
Priority to CA002547782A priority patent/CA2547782A1/en
Priority to AU2004294889A priority patent/AU2004294889B2/en
Priority to EP04801710A priority patent/EP1691782A1/en
Priority to US11/448,766 priority patent/US20070020198A1/en
Priority to US12/255,030 priority patent/US20090038612A1/en
Priority to US12/417,835 priority patent/US20090188497A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0303571A 2003-12-03 2003-12-22 Medical product for moisture-sensitive medicaments SE0303571D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0303571A SE0303571D0 (sv) 2003-12-03 2003-12-22 Medical product for moisture-sensitive medicaments
US10/921,192 US20050123486A1 (en) 2003-12-03 2004-08-19 Medical product containing tiotropium
EP04801710A EP1691782A1 (en) 2003-12-03 2004-12-02 Medical product containing tiotropium
AU2004294889A AU2004294889B2 (en) 2003-12-03 2004-12-02 Medical product containing tiotropium
CA002547782A CA2547782A1 (en) 2003-12-03 2004-12-02 Medical product containing tiotropium
PCT/SE2004/001793 WO2005053647A1 (en) 2003-12-03 2004-12-02 Medical product containing tiotropium
US11/448,766 US20070020198A1 (en) 2003-12-03 2006-06-08 Medical product containing tiotropium
US12/255,030 US20090038612A1 (en) 2003-12-03 2008-10-21 Medical product containing tiotropium
US12/417,835 US20090188497A1 (en) 2003-12-03 2009-04-03 Medical product containing tiotropium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0303269A SE0303269L (sv) 2003-12-03 2003-12-03 Medicinsk produkt
SE0303571A SE0303571D0 (sv) 2003-12-03 2003-12-22 Medical product for moisture-sensitive medicaments

Publications (1)

Publication Number Publication Date
SE0303571D0 true SE0303571D0 (sv) 2003-12-22

Family

ID=30772322

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303571A SE0303571D0 (sv) 2003-12-03 2003-12-22 Medical product for moisture-sensitive medicaments

Country Status (2)

Country Link
US (3) US20050123486A1 (sv)
SE (1) SE0303571D0 (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005053647A1 (en) * 2003-12-03 2005-06-16 Microdrug Ag Medical product containing tiotropium
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
PL2377557T3 (pl) 2004-11-24 2017-05-31 Meda Pharmaceuticals Inc. Kompozycje zawierające azelastynę i sposoby ich zastosowania
RU2422144C2 (ru) * 2005-08-06 2011-06-27 Бёрингер Ингельхайм Интернациональ Гмбх Применение солей тиотропия для лечения тяжелых форм персистирующей астмы
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
NZ570162A (en) * 2006-01-04 2011-09-30 Boehringer Ingelheim Int Use of tiotropium salts in the treatment of moderate persistent asthma which has the serverity of GINA step 3
CA2677573A1 (en) * 2007-02-19 2008-08-28 Cipla Limited Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid
MX357919B (es) * 2009-03-13 2018-07-25 Nucitec Sa De Cv Composición farmacéutica para el tratamiento de la hipercolesterolemia.
WO2010111132A2 (en) 2009-03-27 2010-09-30 Bend Research, Inc. Spray-drying process
WO2011093810A2 (en) * 2010-01-28 2011-08-04 Bilgic Mahmut Dry powder pharmaceutical composition comprising tiotropium and mometasone
WO2011093809A2 (en) * 2010-01-28 2011-08-04 Mahmut Bilgic Dry powder pharmaceutical composition comprising tiotropium and ciclesonide
US8834931B2 (en) 2009-12-25 2014-09-16 Mahmut Bilgic Dry powder formulation containing tiotropium for inhalation
TR201000623A2 (tr) * 2010-01-28 2011-08-22 B�Lg�� Mahmut Yeni tiotropyum kombinasyonu.
TR201000622A2 (tr) * 2010-01-28 2011-08-22 Bi̇lgi̇ç Mahmut Tiotropyum içeren farmasötik kombinasyonlar.
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
US9084976B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
WO2012031133A2 (en) 2010-09-03 2012-03-08 Bench Research, Inc. Spray-drying apparatus and methods of using the same
US9248584B2 (en) 2010-09-24 2016-02-02 Bend Research, Inc. High-temperature spray drying process and apparatus
JP6650933B2 (ja) 2014-10-31 2020-02-19 ベンド リサーチ， インコーポレイテッド マトリックス中に分散された活性薬剤ドメインを形成するためのプロセス
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
SE9904706D0 (sv) * 1999-12-21 1999-12-21 Astra Ab An inhalation device
US6555265B1 (en) * 2000-04-06 2003-04-29 Hawker Energy Products, Inc. Value regulated lead acid battery
GB0009468D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
US20030078947A1 (en) * 2001-10-12 2003-04-24 Intel Corporation Methods for assigning unique identifiers in a distributed fault tolerant application
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
US6591832B1 (en) * 2002-02-21 2003-07-15 Saint-Gobain Calmar Inc. Dry powder dispenser
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
SE525027C2 (sv) * 2002-04-12 2004-11-16 Microdrug Ag Anordning utgörande en pulverlufthyvel
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
GB0225621D0 (en) * 2002-11-02 2002-12-11 Glaxo Group Ltd Medicament carrier
US6591632B1 (en) * 2002-11-19 2003-07-15 Praxair Technology, Inc. Cryogenic liquefier/chiller
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments

Also Published As

Publication number Publication date
US20090188497A1 (en) 2009-07-30
US20050123486A1 (en) 2005-06-09
US20090038612A1 (en) 2009-02-12

Similar Documents

Publication Publication Date Title
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
CY2014028I1 (el) Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης
ATE415968T1 (de) 3,11b-cis-dihydrotetrabanezin zur behandlung von schizophrenie und anderen psychosen
EE200300514A (et) Ftalasinoonid, nende kasutamine hingamisteede haigusnähte leevendavate ravimite valmistamiseks ningneid sisaldavad ravimid
IL189500A (en) 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
EP1651195A4 (en) PHARMACEUTICAL PROCESSES, DOSIERSCHEMATA AND DOSAGE FORMS FOR THE TREATMENT OF ALZHEIMER DISEASE
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
IL165532A (en) History of Aryl Carbonyl, Pharmaceutical Preparations Containing Them and Their Use in the Preparation of Medicines for the Treatment of Metabolic Disorders
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
ITMI20041317A1 (it) Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
NO324227B1 (no) Cyclopropyl-kondenserte pyrrolidin-baserte forbindelser, farmasoytiske blandinger og kombinasjoner inneholdende slike samt anvendelse av slike for fremstilling av medikamenter for behandling av sykdommer
HK1125855A1 (en) Use of oligouronates for treating mucus hyperviscosity
TW200642704A (en) Oral drug delivery system and methods of use thereof
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
UA90504C2 (ru) Лекарственное средство для лечения заболеваний дыхательных путей
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
CY1107231T1 (el) Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης
HRP20070291T3 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
PT1670482E (pt) Utilização de ciclesonida para o tratamento de doenças respiratórias